Abstract
Tumour necrosis factor (TNF)-receptor-associated factors (TRAFs) form a family of cytoplasmic adapter proteins that mediate signal transduction from many members of the TNF-receptor superfamily and the interleukin-1 receptor1. They are important in the regulation of cell survival and cell death. The carboxy-terminal region of TRAFs (the TRAF domain) is required for self-association and interaction with receptors. The domain contains a predicted coiled-coil region that is followed by a highly conserved TRAF-C domain2. Here we report the crystal structure of the TRAF domain of human TRAF2, both alone and in complex with a peptide from TNF receptor-2 (TNF-R2). The structures reveal a trimeric self-association of the TRAF domain, which we confirm by studies in solution. The TRAF-C domain forms a new, eight-stranded antiparallel β-sandwich structure. The TNF-R2 peptide binds to a conserved shallow surface depression on one TRAF-C domain and does not contact the other protomers of the trimer. The nature of the interaction indicates that an SXXE motif may be a TRAF2-binding consensus sequence. The trimeric structure of the TRAF domain provides an avidity-based explanation for the dependence of TRAF recruitment on the oligomerization of the receptors by their trimeric extracellular ligands.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Arch, R. H., Gedrich, R. W. & Thompson, C. B. Tumor necrosis factor receptor-associated factors (TRAFs)—a family of adapter proteins that regulates life and death. Genes Dev. 12, 2821–2830 (1998).
Rothe, M., Wong, S. C., Henzel, W. J. & Goeddel, D. V. Anovel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78, 681–692 (1994).
Boucher, L., Marengere, L. E. M., Lu, Y., Thukral, S. & Mak, T. W. Binding sites of cytoplasmic effectors TRAF1, 2, and 3 on CD30 and other members of the TNF receptor superfamily. Biochem. Biophys. Res. Commun. 233, 592–600 (1997).
Murzin, A. G., Brenner, S. E., Hubbard, T. & Chothia, C. SCOP: a structural classification of protein database for the investigation of sequences and structures. J. Mol. Biol. 247, 536–540 (1995).
Holm, L. & Sander, C. Dali: a network tool for protein structure comparison. Trends Biochem. Sci. 20, 478–480 (1995).
Tainer, J. A., Getzoff, E. D., Beem, K. M., Richardson, J. S. & Richardson, D. C. Determination and analysis of the 2 Å-structure of copper, zinc superoxide dismutase. J. Mol. Biol. 160, 181–217 (1982).
Sutton, R. B., Davletov, B. A., Berghuis, A. M., Sudhof, T. C. & Sprang, S. R. Structure of the first C2 domain of synaptotagmin I: a novel Ca2+/phospholipid-binding fold. Cell 80, 929–938 (1995).
Harbury, P. B., Zhang, T., Kim, P. S. & Alber, T. Aswitch between two-, three-, and four-stranded coiled coil in GCN4 leucine zipper mutants. Science 262, 1401–1407 (1993).
Takeuchi, M., Rothe, M. & Goeddel, D. V. Anatomy of TRAF2. J. Biol. Chem. 271, 19935–19942 (1996).
Janin, J., Miller, S. & Chothia, C. Surface, subunit interfaces and interior of oligomeric proteins. J. Mol. Biol. 204, 155–164 (1988).
Banner, D. W. et al. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 73, 431–445 (1993).
Tong, L. et al. Conserved mode of peptidomimetic inhibition and substrate recognition of human cytomegalovirus protease. Nature Struct. Biol. 5, 819–826 (1998).
Kuriyan, J. & Cowburn, D. Modular peptide recognition domains in eukaryotic signaling. Annu. Rev. Biophys. Biomol. Struct 26, 259–288 (1997).
Regnier, C. H. et al. Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma. J. Biol. Chem. 270, 25715–25721 (1995).
Sunahara, R. K., Tesmer, J. J. G., Gilman, A. G. & Sprang, S. R. Crystal structure of the adenylyl cyclase activator Gsa. Science 278, 1943–1947 (1997).
Arch, R. H. & Thompson, C. B. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κB. Mol. Cell Biol. 18, 558–565 (1998).
Ishida, T. et al. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J.Biol. Chem. 271, 28745–28748 (1996).
Pullen, S. S. et al. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization. Biochemistry 37, 11836–11845 (1998).
Khursigara, G., Orlinick, J. R. & Chao, M. V. Association of tumor necrosis factor receptor-associated protein 6 (TRAF6) with the p75 neurotrophin receptor. J. Biol. Chem. 274, 2597–2600 (1999).
Kuhne, M. R. et al. Assembly and regulation of the CD40 receptor complex in human B cells. J. Exp. Med. 186, 337–342 (1997).
Hsu, H., Shu, H.-B., Pan, M.-G. & Goeddel, D. V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299–308 (1996).
Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997).
Sheldrick, G. M. Phase annealing in SHELX-90: direct methods for larger structures. Acta Crystallogr. A 46, 467–473 (1990).
Tong, L. & Rossmann, M. G. Patterson-map interpretation with noncrystallographic symmetry. J.Appl. Crystallgr. 26, 15–21 (1993).
Furey, W. Phases: a program package for the processing and analysis of diffraction data for macromolecules (VA Medical Center, Pittsburgh, (1993).
Jones, T. A., Zou, J.-Y., Cowan, S. W. & Kjeldgaard, M. Improved methods for building models in electron density maps and the location of errors in those models. Acta Crystallgr. A 47, 110–119 (1991).
Brunger, A. T. et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D 54, 905–921 (1998).
Tong, L. REPLACE, a suite of computer programs for molecular-replacement calculations. J. Appl. Crystallogr. 26, 748–751 (1993).
Nicholls, A., Sharp, K. A. & Honig, B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11, 281–296 (1991).
Evans, S. V. SETOR: hardware-lighted three-dimensional solid model representations of macromolecules. J. Mol. Graph. 11, 134–138 (1993).
Acknowledgements
We thank W. Hendrickson for discussions; T. Burling for maintaining the X-ray equipment and computers; C. Ogata for assistance at the X4A beamline of NSLS; members of the CHESS for help at the F2 beamline; M. Lu for running the analytical ultracentrifugation experiments; C. Lima for help with the SETOR program; and G. Douglas and M. Cervantes for summer research in the laboratory.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, Y., Burkitt, V., Villa, A. et al. Structural basis for self-association and receptor recognition of human TRAF2. Nature 398, 533–538 (1999). https://doi.org/10.1038/19110
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/19110
This article is cited by
-
Epstein-Barr virus-driven B cell lymphoma mediated by a direct LMP1-TRAF6 complex
Nature Communications (2024)
-
Agglomeration: when folded proteins clump together
Biophysical Reviews (2023)
-
TNF receptor agonists induce distinct receptor clusters to mediate differential agonistic activity
Communications Biology (2021)
-
Structural feature of TRAFs, their related human diseases and therapeutic intervention
Archives of Pharmacal Research (2021)
-
Structural analysis of TIFA: Insight into TIFA-dependent signal transduction in innate immunity
Scientific Reports (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.